These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3535832)

  • 41. Production of stable heterohybridomas producing human monoclonal antibodies.
    Cooper MD; Kirkpatrick R
    Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
    [No Abstract]   [Full Text] [Related]  

  • 42. Generation of monoclonal antibodies against chromosomal antigens that have a high sequence similarity between human and mouse.
    Higashi T; Miyakawa S; Uchiyama S; Matsunaga S; Takata H; Fujimoto S; Noda M; Terauchi A; Shimizu T; Oda M; Azuma T; Fukui K
    J Biotechnol; 2005 Nov; 120(3):262-72. PubMed ID: 16171883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
    Kobayashi Y; Asada M; Higuchi M; Osawa T
    J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Monoclonal antibodies as laboratory reagents].
    Fossati CA
    Rev Argent Microbiol; 1983; 15(1):57-64. PubMed ID: 6400762
    [No Abstract]   [Full Text] [Related]  

  • 45. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Entrapment of animal cells for production of monoclonal antibodies and other biomolecules.
    Nilsson K; Scheirer W; Merten OW; Ostberg L; Liehl E; Katinger HW; Mosbach K
    Nature; 1983 Apr; 302(5909):629-30. PubMed ID: 6300692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development, screening and quality specifications of hybridomas synthesizing anti-polypeptide hormone antibodies to be used for diagnostic tests and in-process control.
    Schönherr OT; Roelofs HW; Houwink EH
    Dev Biol Stand; 1983; 55():163-71. PubMed ID: 6677529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Establishment and identification of the monoepitopic monoclonal antibody of Plasmodium falciparum].
    Qu J; Yang B; Bao Y; Yang Y; Xu Y; Xu X; Fan P; Ren Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):338-41. PubMed ID: 12563727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of monoclonal antibodies in tropical diseases research.
    Tharavanij S
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):371-84. PubMed ID: 6084305
    [No Abstract]   [Full Text] [Related]  

  • 51. Monoclonal antibodies, hybridoma technology and heterologous production systems.
    Hiatt AC
    Curr Opin Immunol; 1991 Apr; 3(2):229-32. PubMed ID: 2069749
    [No Abstract]   [Full Text] [Related]  

  • 52. [Preparation of monoclonal antibody and its application for plant cell biochemistry].
    Aoki K; Saitoh H; Ideguchi T; Miyazaki K; Kakuno T; Yamashita J; Horio T
    Tanpakushitsu Kakusan Koso; 1987 Jul; (30 Suppl):171-85. PubMed ID: 3334466
    [No Abstract]   [Full Text] [Related]  

  • 53. Monoclonal antibodies: current status in eye research.
    Char DH
    Int Ophthalmol Clin; 1985; 25(2):43-54. PubMed ID: 3891658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical applications of monoclonal antibodies.
    Maudgil KD; Gupta SK; Narang BS
    Indian J Pediatr; 1984; 51(413):689-701. PubMed ID: 6399494
    [No Abstract]   [Full Text] [Related]  

  • 55. Hybridoma technology identifies protective malaria antigens.
    Cox FE
    Nature; 1981 Dec; 294(5842):612. PubMed ID: 7312049
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients].
    Bermudez LE
    Rev Paul Med; 1987; 105(6):341-6. PubMed ID: 3332929
    [No Abstract]   [Full Text] [Related]  

  • 57. [Anti-Leishmania monoclonal antibodies of hybridoma origin].
    Infante RB; Lynch NR; Malavé C; Convit J
    Acta Cient Venez; 1986; 37(3):334-5. PubMed ID: 3303778
    [No Abstract]   [Full Text] [Related]  

  • 58. Developmental aspects of immunologically characterized proteins.
    Falkenberg FW; Gantenberg W; Jürgenliemk I; Mayer M; Pierard D; Riffelmann HD; Behrendt B; Waks T
    Clin Biochem; 1983 Feb; 16(1):10-6. PubMed ID: 6861333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Monoclonal antibodies. New possibilities for research and practice].
    Batsford SR; Wenzel-Elias I
    ZFA (Stuttgart); 1982 Oct; 58(30):1635-9. PubMed ID: 7157952
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-animal-derived monoclonal antibodies are not ready to substitute current hybridoma technology.
    González-Fernández Á; Bermúdez Silva FJ; López-Hoyos M; Cobaleda C; Montoliu L; Del Val M; Leech K
    Nat Methods; 2020 Nov; 17(11):1069-1070. PubMed ID: 33020658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.